Additionally, targeting the epigenetic machinery has been proven as an efficient anti-cancer strategy in several tumor types, albeit it remains an open question whether Cbx3/HP1γ or Cbx7 epigenetic factors could become novel therapeutic targets in stem cell-like tumors. This evidence concerns the gene CBX3 and neoplasm.